Seoul, July 2: South Korea’s pharmaceutical exports have surpassed $10 billion for the first time in 2025, marking a major milestone for the country’s healthcare and biotechnology sector.
The strong performance has been driven by rising global demand for biosimilars, vaccines, and advanced drug formulations developed by South Korean companies. Industry experts say increased overseas approvals and expanded production capacity have also contributed to the growth.
Officials and analysts view this achievement as a sign of South Korea’s growing competitiveness in the global pharmaceutical market, with expectations of continued expansion in the coming years.